granted
on 28 Mar 2024
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
97530456 filed on 02th Aug 2022
Registration Number
N/A
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, CoronaviruRead More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
No 97530456
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
24.15.04 -
Arrowheads
24.15.10 -
More than one arrow
24.15.25 -
Other arrows
The mark consists ofthe wording "ZEPBOUND" in stylized font, with a cutout of an arrowhead on the left side of the letter "B" and three arrowheads after the word.
| Status Date | Action Taken |
|---|---|
| 29th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 28th Mar 2024 | SOU EXTENSION 2 FILED |
| 28th Mar 2024 | SOU EXTENSION 2 GRANTED |
| 19th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
| 17th Oct 2023 | SOU EXTENSION 1 FILED |
| 17th Oct 2023 | SOU EXTENSION 1 GRANTED |
| 16th May 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 21st Mar 2023 | PUBLISHED FOR OPPOSITION |
